Grafa News and Videos — Page 224

PowerBank (NASDAQ:PBK) reported fiscal 2026 financial results, with lower revenue but improved gross margins and a narrower net loss.

SLB (NYSE:SLB) announced that its OneSubsea joint venture has been awarded a contract by ExxonMobil Moçambique, Limitada, on behalf of its Area 4 partners, to deliver subsea production systems for the first phase of the offshore Rovuma LNG project in Mozambique.

Aldeyra Therapeutics (NASDAQ:ALDX) announced plans to submit a Formal Dispute Resolution Request (FDRR) to the U.S. Food and Drug Administration (FDA) seeking review of the agency’s decision not to approve reproxalap, its investigational therapy for dry eye disease.

Unicycive Therapeutics (NASDAQ:UNCY) resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration for oxylanthanum carbonate, an investigational treatment for hyperphosphatemia in patients receiving dialysis.

uniQure (NASDAQ:QURE) reported additional Phase I/II data for ifezuntirgene inilparvovec, its investigational gene therapy for Huntington’s disease, with follow-up results extending to 36 and 48 months.

Invivyd (NASDAQ:IVVD) reported Phase 3 LIBERTY trial results showing that its investigational COVID-19 antibody product VYD2311 demonstrated fewer reported adverse events compared with an mRNA COVID-19 vaccine.

IM Cannabis (NASDAQ:IMCC) completed the sale of IMC Holdings to Slil, following a transaction that included a previously paid C$3 million payment as part of the consideration.

Eli Lilly (NYSE:LLY) reported an indirect comparison suggesting that Zepbound 10 mg and 15 mg were associated with greater weight loss than Wegovy HD 7.2 mg in adults with obesity.

Scholastic (NASDAQ:SCHL) signed a definitive agreement to acquire Cottage Door Press for approximately $71 million, subject to customary purchase price adjustments.

Scorpio Tankers (NYSE:STNG) announced agreements to sell three product tankers and acquire four newbuilding vessels as part of its fleet management strategy.